Background: Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
induces a prothrombotic state, but long-term effects of COVID-19 on incidence of vascular …

Objective To assess the associations between coronavirus disease 2019 (COVID-19)
infection and thromboembolism including myocardial infarction (MI), ischemic stroke, deep …

Background There are few data on the incidence of thrombosis among COVID-19 cases,
with most research concentrated on hospitalised patients. We aimed to estimate the …

Abstract Coronavirus disease-2019 (COVID-19), a viral respiratory illness caused by the
severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2), may predispose patients …

Background The prevalence of venous thromboembolic event (VTE) and arterial
thromboembolic event (ATE) thromboembolic events in patients with COVID-19 remains …

Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome
(SARS-CoV-2) is associated with a heightened risk of thrombotic events. 1 We sought to …

Objective To quantify the risk of deep vein thrombosis, pulmonary embolism, and bleeding
after covid-19. Design Self-controlled case series and matched cohort study. Setting …

Introduction: Novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
infection resulting in COVID-19 disease is associated with widespread inflammation and a …

Data regarding the occurrence of venous thromboembolic events (VTE), including acute
pulmonary embolism (PE) and deep vein thrombosis (DVT) in recovered COVID-19 patients …

Background The reported incidence of venous thromboembolism (VTE) in COVID-19
patients varies widely depending on patient populations sampled and has been …